Equity Overview
Price & Market Data
Price: $304.0
Daily Change: +$0.38 / 0.13%
Range: $299.6 - $308.8
Market Cap: $21,438,304,256
Volume: 665,887
Performance Metrics
1 Week: -2.29%
1 Month: -5.22%
3 Months: 19.26%
6 Months: 10.86%
1 Year: 58.53%
YTD: 16.69%
Company Details
Employees: 3900
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.